(CIDRAP News) – Tests by federal health officials have detected bacterial contamination in two products from the Massachusetts compounding pharmacy linked to a multistate fungal meningitis outbreak caused by tainted steroid drugs, a finding that amplifies worries about the sterility of the company's products.
(CIDRAP News) – Nine more patients have been sickened in a multistate fungal meningitis outbreak linked to a Massachusetts company's tainted steroid injections, boosting the total so far to 386, the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) – A second compounding pharmacy today recalled all of its products in the wake of Food and Drug Administration (FDA) investigations surrounding a multistate fungal meningitis outbreak linked to contaminated injectable steroids.
Oct 30, 2012
(CIDRAP News) – Safety problems with products from compounding pharmacies even before the current multistate fungal meningitis outbreak led to at least 23 deaths and 86 serious illnesses or injuries in 34 states over the past decade, according to a report today from a Massachusetts congressman.
(CIDRAP News) – The compounding pharmacy that produced tainted steroid injections implicated in a multistate fungal meningitis outbreak had problems maintaining the clean room where the drugs were processed, according to a federal report today that found, for example, greenish residue on the ceiling.
Oct 25, 2012
(CIDRAP News) – Massachusetts officials yesterday said New England Compounding Center (NECC), the firm linked to a multistate fungal meningitis outbreak, sent shipments from two of the recalled lots before it received sterility testing results.
(CIDRAP News) – Eleven more cases were reported in a multistate fungal meningitis outbreak linked to contaminated steroid injections, including the first patient from Georgia, the US Centers for Disease Control and Prevention (CDC) reported today.
Oct 22, 2012